Transit Time and Bacterial Overgrowth Using SmartPill Capsule
Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this exploratory study is to measure orocecal transit time using the
SmartPill ambulant capsule technology and to compare this with the lactulose hydrogen breath
test. Additionally, the ability of the SmartPill GI Monitoring System to discriminate between
healthy human subjects and patients with small bowel bacterial overgrowth will be explored
using analyses of both pH and pressure patterns within the stomach and small intestine. The
study will be performed in both normal subjects and patients with and without small bowel
bacterial overgrowth.